An original outbreak of Ebola virus disease that begun in West Africa in December 2013, mainly affecting Guinea, Liberia and Sierra Leone has now ended.
ECDC promotes the performance of external quality assessment (EQA) schemes, in which laboratories are sent simulated clinical specimens or bacterial isolates for testing by routine or reference laboratory methods. EQA schemes, or laboratory proficiency testing, provide information about the accuracy of different characterisation and typing methods as well as antimicrobial susceptibility testing (AST) and the sensitivity of the methods in place to detect a certain pathogen or novel resistance patterns.
The EHFG is the leading health policy event in the EU and takes place annually. It provides a major platform for decision-makers in various fields of public health and health care.
ECDC Director Marc Sprenger addressed MEPs of the European Parliament’s Committee on the Environment, Public Health and Food Safety regarding the ongoing Ebola virus disease outbreak in West Africa.
Multi-drug resistant Salmonella bacteria continue to spread across Europe, show the latest data on resistance in bacteria in humans, food and animals issued by ECDC and EFSA. There’s evidence of resistance to the antimicrobial colistin in Salmonella among poultry in the EU - this last-resort drug may soon no longer be effective for treating severe human infections with Salmonella.
This workshop on AMR in Salmonella and Campylobacter was arranged in cooperation with the FWD Network and the EU reference laboratory for antimicrobial resistance network.